Global Cell Separation Technologies Market to Reach US$ 22.2 Billion by 2028, Impelled by Increasing Product Utilization In Pharmaceutical Sector

April 10, 2023 | Healthcare

According to the latest report by IMARC Group, titled “­­Cell Separation Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global cell separation technologies market size reached US$ 9.0 Billion in 2022. Cell separation technologies, also known as cell isolation or cell sorting, are techniques used to separate specific cell types from a heterogeneous population of cells based on their extracellular properties. They are essential in many areas of biological research, such as immunology, cancer biology, stem cell research, and regenerative medicine. Some of the standard techniques employed for cell separation include microfluidic cell sorting, fluorescence-activated cell sorting (FACS), magnetic-activated cell sorting (MACS), immunogenicity cell isolation, and density gradient configuration. These technologies find numerous applications in the healthcare sector, such as isolating rare tumor cells or stem cells for further analysis or therapeutic purposes. In addition to this, they are widely employed for studying cellular heterogeneity, which is critical for understanding the mechanisms of disease and developing personalized medicine approaches. 


Global Cell Separation Technologies Market Trends:

The expanding adoption of cell separation technologies in the flourishing pharmaceutical sector to improve drug discovery and develop drugs with enhanced efficacies is primarily driving the market growth. Besides this, the introduction of advanced isolation tools that enable the continuous examination of nucleic acids, chromatin, proteins, and other complex cells is presenting remunerative growth opportunities for the market. Moreover, the rising demand for personalized and regenerative medicines, an increased focus on stem cell research, and growing product utilization for producing vaccines for various diseases, such as influenza, human papillomavirus (HPV), and rotavirus, are creating a positive outlook for the market. Concurrent with this, extensive investments in research and development (R&D) activities in the biotechnology sector to develop novel cell-based treatments and therapies for various chronic diseases are aiding in market expansion. In addition to this, the widespread prevalence of chronic conditions, such as cancer, acquired immune deficiency syndrome (AIDS), and cystic fibrosis, particularly among the geriatric population, is impelling the market growth. Furthermore, the implementation of initiatives undertaken by governments of various countries to fortify healthcare infrastructure by enhancing cell-based technology is strengthening the market growth. Looking forward, the market value is projected to reach US$ 22.2 Billion by 2028, expanding at a CAGR of 15.6% during 2023-2028. 


Market Summary:

  • Based on the product, the market is bifurcated into instruments and consumables.
  • On the basis of the cell type, the market has been divided into human and animal cells.
  • Based on technology, the market is categorized into centrifugation-based, surface marker-based, and filtration-based cell separation.
  • On the basis of the application, the market has been segregated into oncology research, neuroscience research, stem cell research, microbiology, immunology research, and others.
  • Based on the end user, the market is classified into research laboratories and institutes, biotechnology and biopharmaceutical companies, and cell banks.
  • On a regional basis, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc.

Report Scope:

Report Features Details
Base Year of the Analysis 2022
Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Billion
Segment Coverage Product, Cell Type, Technology, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Cell Separation Technologies Market to Reach US$ 22.2 Billion by 2028, Impelled by Increasing Product Utilization In Pharmaceutical Sector
Purchase options Year End sale



Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More